Cofoe Medical Sets 28 Aug 2026 Board Meeting to Approve 1H 2026 Interim Results and Dividend Proposal

Bulletin Express

08/14

Cofoe Medical Technology Co., Ltd. announced that its board of directors will convene on 28 August 2026 to review and approve the unaudited interim results of the Company and its subsidiaries for the six-month period ended 30 June 2026. The agenda also includes considering a potential interim dividend recommendation and addressing other business matters.

The board currently comprises four executive directors—Zhang Min (Chairman), Zhang Zhiming, Xue Xiaoqiao and He Bangjie—and three independent non-executive directors—Ning Huabo, Shen Nan and Zhou Rong.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1176343321"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1176343321\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1176343321?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-14 16:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1176343321","market":"us","top_or_hot":-1,"title":"Cofoe Medical Sets 28 Aug 2026 Board Meeting to Approve 1H 2026 Interim Results and Dividend Proposal","media":"Bulletin Express","content":"<p>Cofoe Medical Technology Co., Ltd. announced that its board of directors will convene on 28 August 2026 to review and approve the unaudited interim results of the Company and its subsidiaries for the six-month period ended 30 June 2026. The agenda also includes considering a potential interim dividend recommendation and addressing other business matters.</p>\n<p>The board currently comprises four executive directors—Zhang Min (Chairman), Zhang Zhiming, Xue Xiaoqiao and He Bangjie—and three independent non-executive directors—Ning Huabo, Shen Nan and Zhou Rong.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cofoe Medical Sets 28 Aug 2026 Board Meeting to Approve 1H 2026 Interim Results and Dividend Proposal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCofoe Medical Sets 28 Aug 2026 Board Meeting to Approve 1H 2026 Interim Results and Dividend Proposal\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-08-14 16:47</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Cofoe Medical Technology Co., Ltd. announced that its board of directors will convene on 28 August 2026 to review and approve the unaudited interim results of the Company and its subsidiaries for the six-month period ended 30 June 2026. The agenda also includes considering a potential interim dividend recommendation and addressing other business matters.</p>\n<p>The board currently comprises four executive directors—Zhang Min (Chairman), Zhang Zhiming, Xue Xiaoqiao and He Bangjie—and three independent non-executive directors—Ning Huabo, Shen Nan and Zhou Rong.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01187","symbol_name":"可孚醫療","start_time":0,"source_url":"","article_id":"1176343321","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1176343321","pubTimestamp":1786697265,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Cofoe Medical Technology Co., Ltd. announced that its board of directors will convene on 28 August 2026 to review and approve the unaudited interim results of the Company and its subsidiaries for the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01187":"可孚医疗"},"translate_title":"Cofoe Medical Sets 2026 年 8 月 28 日董事会会议批准 2026 年上半年中期业绩和股息提案","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01187":1},"content_text":"Cofoe Medical Technology Co., Ltd. announced that its board of directors will convene on 28 August 2026 to review and approve the unaudited interim results of the Company and its subsidiaries for the six-month period ended 30 June 2026. The agenda also includes considering a potential interim dividend recommendation and addressing other business matters.\nThe board currently comprises four executive directors—Zhang Min (Chairman), Zhang Zhiming, Xue Xiaoqiao and He Bangjie—and three independent non-executive directors—Ning Huabo, Shen Nan and Zhou Rong.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}